Darwin Global Management, Ltd. 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Darwin Global Management, Ltd. disclosed 6 US equity positions worth $3.8bn in its Q1 2026 13F filing. The largest position was INSM at 68.3% of the reported book, followed by BLTE and ABVX.
What did Darwin Global Management, Ltd. own in Q1 2026? Top 6 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | INSM INSMED INC | Healthcare | 68.3% | $2.6bn | 16,805,184 | – | |
| 2 | BLTE BELITE BIO INC | Healthcare | 12.1% | $456.1m | 3,057,412 | – | |
| 3 | ABVX ABIVAX SA | Healthcare | 9.3% | $352.1m | 3,468,657 | – | |
| 4 | RVMD REVOLUTION MEDICINES INC | Healthcare | 5.4% | $205.0m | 2,211,018 | – | |
| 5 | ROIV ROIVANT SCIENCES LTD | Healthcare | 4.8% | $179.5m | 6,797,300 | – | |
| 6 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 0.0% | $1.5m | 17,357 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.